Kedalion Therapeutics

Menlo Park, United States

Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.

Nov 2021

Series B

Biotechnology Health Care Therapeutics

Top Investors

Novartis Venture Fund Lagunita BioSciences

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kedalion Therapeutics

Who are Kedalion Therapeutics's investors?

Kedalion Therapeutics's investors include Novartis Venture Fund, Lagunita BioSciences.

Where is Kedalion Therapeutics headquartered?

Kedalion Therapeutics is headquartered in Menlo Park, United States.

What does Kedalion Therapeutics do?

Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.

What stage is Kedalion Therapeutics at?

Kedalion Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 15, 2021.

MLA

"Kedalion Therapeutics — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/kedalion-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Kedalion Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kedalion-therapeutics

Wikipedia (cite web)

{{cite web |title=Kedalion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kedalion-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 15, 2021.